Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Revenue: 2023-2024

Historic Revenue for Praxis Precision Medicines (PRAX) over the last 2 years, with Dec 2024 value amounting to $8.6 million.

  • Praxis Precision Medicines' Revenue rose 1365.23% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 million, marking a year-over-year increase of 1286.92%. This contributed to the annual value of $8.6 million for FY2024, which is 249.53% up from last year.
  • Praxis Precision Medicines' Revenue amounted to $8.6 million in FY2024, which was up 249.53% from $2.4 million recorded in FY2023.
  • Over the past 5 years, Praxis Precision Medicines' Revenue peaked at $8.6 million during FY2024, and registered a low of $2.4 million during FY2023.
  • Moreover, its 2-year median value for Revenue was $5.5 million (2023), whereas its average is $5.5 million.
  • Data for Praxis Precision Medicines' Revenue shows a peak YoY spiked of 249.53% (in 2024) over the last 5 years.
  • Praxis Precision Medicines' Revenue (Yearly) stood at $2.4 million in 2023, then spiked by 249.53% to $8.6 million in 2024.